OPTIGENEX INC. – Trademark Portfolio

Entity Type: 03

OPTIGENEX INC. holds 28 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 25 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include AC-11, ACTIVAR, REVINIA, C-MED 100, and 100 C-MED DNA REPAIR. The owner is based in NEW YORK, NY.

750 LEXINGTON AVENUE

NEW YORK, NY 10022

28 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (28 results)

Trademark Classifications

OPTIGENEX INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (25 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (7 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does OPTIGENEX INC. have?

OPTIGENEX INC. has 28 U.S. trademarks filed with the USPTO. Of these, 7 registered, 10 abandoned, 11 cancelled.

What trademark classes does OPTIGENEX INC. file in?

OPTIGENEX INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are OPTIGENEX INC.'s most well-known trademarks?

OPTIGENEX INC.'s registered trademark portfolio includes well-known marks such as AC-11, ACTIVAR, REVINIA, C-MED 100, and 100 C-MED DNA REPAIR. These are among 7 currently registered trademarks in the portfolio.

What is OPTIGENEX INC.'s trademark registration success rate?

OPTIGENEX INC. has a 25% trademark registration rate, with 7 out of 28 resolved applications resulting in successful registration. Currently, 0 applications are pending review.